Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Eur J Prev Cardiol ; 28(13): 1501-1507, 2021 10 25.
Artículo en Inglés | MEDLINE | ID: mdl-34695216

RESUMEN

BACKGROUND: Environmental pollution and weather changes unfavorably impact on cardiovascular disease. However, limited research has focused on ST-elevation myocardial infarction (STEMI), the most severe yet distinctive form of acute coronary syndrome. METHODS AND RESULTS: We appraised the impact of environmental and weather changes on the incidence of STEMI, analysing the bivariate and multivariable association between several environmental and atmospheric parameters and the daily incidence of STEMI in two large Italian urban areas. Specifically, we appraised: carbon monoxide (CO), nitrogen dioxide (NO2), nitric oxide (NOX), ozone, particulate matter smaller than 10 µm (PM10) and than 2.5 µm (PM2.5), temperature, atmospheric pressure, humidity and rainfall. A total of 4285 days at risk were appraised, with 3473 cases of STEMI. Specifically, no STEMI occurred in 1920 (44.8%) days, whereas one or more occurred in the remaining 2365 (55.2%) days. Multilevel modelling identified several pollution and weather predictors of STEMI. In particular, concentrations of CO (p = 0.024), NOX (p = 0.039), ozone (p = 0.003), PM10 (p = 0.033) and PM2.5 (p = 0.042) predicted STEMI as early as three days before the event, as well as subsequently, and NO predicted STEMI one day before (p = 0.010), as well as on the same day. A similar predictive role was evident for temperature and atmospheric pressure (all p < 0.05). CONCLUSIONS: The risk of STEMI is strongly associated with pollution and weather features. While causation cannot yet be proven, environmental and weather changes could be exploited to predict STEMI risk in the following days.


Asunto(s)
Contaminantes Atmosféricos , Contaminación del Aire , Infarto del Miocardio con Elevación del ST , Contaminantes Atmosféricos/efectos adversos , Contaminación del Aire/efectos adversos , Contaminación Ambiental/análisis , Humanos , Incidencia , Material Particulado/efectos adversos , Infarto del Miocardio con Elevación del ST/diagnóstico , Infarto del Miocardio con Elevación del ST/epidemiología , Tiempo (Meteorología)
2.
Catheter Cardiovasc Interv ; 96(3): 638-642, 2020 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-32315110

RESUMEN

Percutaneous suture-mediated transcatheter patent fossa ovalis (PFO) closure has been shown to be an effective and safe technique with self-evident advantages due to the lack of a permanent device heart implant. The success of this novel technique relies on an optimal catch of the interatrial septa, especially the septum primum which is floppier than the bulkier muscular septum secundum. We hypothesized that double suture of septum primum would further improve the efficacy of the procedure by increasing the surface contact between the septa when the septum primum is bent into the right atrium. We have provided proof of this concept by implementing a modified technique in two patients with PFO and cerebral ischemic events.


Asunto(s)
Isquemia Encefálica/prevención & control , Cateterismo Cardíaco , Embolia Paradójica/prevención & control , Foramen Oval Permeable/terapia , Técnicas de Sutura , Adulto , Isquemia Encefálica/etiología , Isquemia Encefálica/fisiopatología , Embolia Paradójica/etiología , Embolia Paradójica/fisiopatología , Femenino , Foramen Oval Permeable/complicaciones , Foramen Oval Permeable/diagnóstico por imagen , Foramen Oval Permeable/fisiopatología , Humanos , Persona de Mediana Edad , Resultado del Tratamiento
3.
Case Rep Cardiol ; 2019: 5956806, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31485355

RESUMEN

Coronary artery fistulas are rare abnormal connections between a coronary artery and a cardiac chamber or a major vessel. Often, they are asymptomatic and the diagnosis is accidental. The case we present is the incidental finding of a fistula displayed with echocardiography during acute coronary syndrome (ACS). A 73-year-old man presented in the emergency room for non-ST-elevation ACS. Echocardiogram showed in a parasternal short axis view an abnormal diastolic flow inside the ventricular inferior wall. Angiography and CT confirmed the diagnosis of coronary fistula from the right coronary into the left ventricular cavity. A literature analysis with discussion about coronary fistulas classification and management was also performed.

4.
J Cardiovasc Med (Hagerstown) ; 18(5): 291-294, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28306693

RESUMEN

Cocaine is associated with important cardiac complications such as sudden death, acute myocarditis, dilated cardiomyopathy, life-threatening arrhythmias, and myocardial ischemia as well as infarction. It is well known that cocaine may induce vasospasm through adrenergic stimulation of the coronary arteries. Moreover, cocaine may promote intracoronary thrombosis, triggered by alterations in the plasma constituents, and platelet aggregation, leading to subsequent myocardial infarction. The long-term use of cocaine may stimulate atherosclerosis, probably through endothelial cell dysfunction. Significant and severe coronary atherosclerosis is common in young chronic cocaine users and there is probably a relationship between the duration and frequency of cocaine use and the extent of coronary disease.


Asunto(s)
Estimulantes del Sistema Nervioso Central/efectos adversos , Trastornos Relacionados con Cocaína/complicaciones , Cocaína/efectos adversos , Enfermedad de la Arteria Coronaria/inducido químicamente , Vasoespasmo Coronario/inducido químicamente , Vasos Coronarios/efectos de los fármacos , Trombosis/inducido químicamente , Trombosis/diagnóstico por imagen , Animales , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Enfermedad de la Arteria Coronaria/fisiopatología , Circulación Coronaria/efectos de los fármacos , Vasoespasmo Coronario/diagnóstico por imagen , Vasoespasmo Coronario/fisiopatología , Vasos Coronarios/diagnóstico por imagen , Vasos Coronarios/fisiopatología , Hemodinámica/efectos de los fármacos , Humanos , Pronóstico , Medición de Riesgo , Factores de Riesgo , Trombosis/fisiopatología
5.
Nephrourol Mon ; 7(4): e28099, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-26528445

RESUMEN

CONTEXT: Coronary artery disease is highly prevalent among patients with end stage renal disease/hemodialysis (ESRD/HD) and coronary percutaneous interventions (PCI) has been increased by nearly 50% over the past decade. After PCI with stent placement, guidelines recommend dual antiplatelet therapy (DAPT), but no specifically tailored pharmacotherapy approach is outlined for this frail population, mostly excluded from large randomized clinical trials (RCTs). EVIDENCE ACQUISITION: We reviewed current evidences on the use of antiplatelet therapy in patients with ESRD/HD undergoing PCI, focusing on the efficacy and safety of specific agents and their indications for detailed clinical settings. RESULTS: Clinical setting in HD patients is the principal determinant of the type, onset, combination and duration of the DAPT. However, irrespective clinical setting, in addition to aspirin, clopidogrel is currently the most used antiplatelet agent even if no information derived from RCTs are available in ESRD. Due to the large experience acquired in routine clinical practice, the awareness of safety is higher for clopidogrel than newer antiplatelet agents. Because of lack of data, the use of prasugrel and ticagrelor is actually not recommended. However, in case of high ischemic and acceptable bleeding risk, they may be selectively used in ESRD/HD. CONCLUSIONS: This investigation might contribute to delineate the best treatment options for this high risk population.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...